What is MSMDS

WHAT IS MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME?

Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS) is the most severe and early-onset condition associated with mutations in the ACTA2 gene.


It affects smooth muscle throughout the body and can involve multiple organ systems from birth. Early recognition is key to improving outcomes and guiding appropriate care.

Genetic causes of MSMDS

Multisystemic Smooth Muscle Dysfunction Syndrome is most commonly caused by mutations in the ACTA2 gene, particularly affecting the Arg179 and Arg258 position.


Some cases linked to other genes (such as MYH11 or miRNA-145) have also been described.


Understanding the genetic basis is essential for diagnosis, family counselling, and research.


VIDEO:

Known Causes of Multisystemic Smooth Muscle Dysfunction Syndrome, Dr. Mark Lindsay, MD (MGH)

Watch Video

A multisystem condition from birth

MSMDS affects the function of smooth muscle across different organs, which explains the wide range of symptoms seen in patients.


Early signs may include:

  • Dilated pupils from birth (often the first visible sign)
  • Congenital heart defects
  • Neurological findings such as white matter changes or stroke
  • Gastrointestinal and respiratory complications
  • Urinary tract involvement (including megacystis)


Because these features are often treated as separate conditions, MSMDS can be under-recognized or diagnosed late.

Explore signs & symptoms

Challenges in diagnosis

Diagnosing MSMDS can be complex due to its rarity and variability.



  • Many clinicians may not be familiar with the condition
  • Symptoms are often managed individually rather than as part of a syndrome
  • Some routine procedures may carry additional risks in ACTA2 patients


Early suspicion, especially in the presence of congenital mydriasis, is essential to prompt genetic testing and appropriate care.


Diagnostic Journey of MSMDS

Current management and care

There is currently no cure for MSMDS, but management focuses on reducing risks and treating complications.

This may include:

  • Cardiac and vascular monitoring
  • Surgical interventions with adapted anesthesia protocols
  • Neurological follow-up
  • Supportive therapies tailored to each patient


Clinical care is evolving, with growing expertise and the development of specialized protocols.


Learn about treatments and care

FEATURED: RESOURCES FOR FAMILIES

FEATURED: RESOURCES FOR CLINICIANS/RESEARCHERS